Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-02-19
2000-08-29
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 49, A61K 3170
Patent
active
061109010
ABSTRACT:
The present invention relates to methods for controlling and/or treating RNA-replicating viral infections which afflict human beings, animals and/or plants. Specifically, the RNA chain terminating agents, 3'-deoxyribouracil, 3'-deoxyriboguanine and 3'-deoxyribocytosine are useful in treating RNA-replicating viral infections.
REFERENCES:
patent: 4665062 (1987-05-01), Eriksson et al.
patent: 4968690 (1990-11-01), Morquez et al.
Gosselin, G. et al., Systematic Synthesis and Biological Evaluation of alpha- and beta-D-Xylofuranosyl Nucleosides of the five naturally occurring bases in nucleic acids and related analogue. J. Med. Chem. 1986,29,203-214.
Axelrod, V.D. et al. R.S. Specific termination of RNA polymerase synthesis as a method of RNA and DNA sequencing. Nucleic Acids. Res. 1978,5, 549-3553.
Axelrod, V.D., et al. Transcription from bacteriophage T7 and SP6 RNA polymerase promoters in the prescense of 3'-deoxyribonucleoside 5'-triphosphate chain terminators. Biochemistry, 1985,24,5716-5723.
Goswami, B B. and Sharma, S.K. Inhibition of vaccinia virus growth and virus-specific RNA synthesis by 3'-O-methyl adenosine and 3'-O-methyl guanosine. J. Virology. 1983,45,1164-1167.
Puech, F., Gosselin, G., Imbach, J-L. Synthesis of 9-(3-Deoxy-3-fluor-D-ribofuranosyl)guanine, a new potent antiviral agent. J. Chem. Socl, chem. Commun., 1989,955-957.
Plotch, S. J. Palant, O., and Gluzman Y. Purification and properties of poliovirus RNA polymerase expressed in Escherichia coli, J. Virology, 1989, 63,216-225.
Plotch, S. J. and Krug, R.M. Influenze virion transcriptase: Synthesis in vitro of large, polyadenylic acid-containing complementary RNA. J. Virology, 1977,21,24-24.
Plotch, S. J. Tomasz, J.M. and Krug, R.M. Absence of detectable capping and methylating enzymes in influenzae virions. J. Virology, 1978,28,75-83.
Beckes, J.D., Haller, A.A., and Perralut, J. Differential effect of ATP concentration on synthesis of vesicular stomatitus virus leader RNAs and mRNAs. J. Virology, 1987, 61,3470-3478.
Tuschall, M. Hiebert E., et al., Poliovirus RNA-dependent RNA polymerase synthesized full-length copies of poliovirion RNA, cellular mRNA, and several plant virus RNA in vitro. J. Virology. 1982,44,209-216.
Yokota et al CA 113: 184252q 1990.
Morozumi et al CA 111: 154308d 1989.
Webb et al CA 109: 23303v 1988.
Widell et al CA 104: 199470x 1986.
Akherm et al CA: 95533h 1978.
Kraus et al CA 113: 147783 1990.
Schuman et al CA 109: 88675b 1988.
Eriksson et al CA 112: 18103b 1989.
Gluzman Yakov
Ostrander Michael
American Cyanamid Company
Buit Larry
Rosenblum Anne M.
Travers Russell
Tsevdos Estelle J.
LandOfFree
Method for treating RNA viral infections by using RNA chain term does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating RNA viral infections by using RNA chain term, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating RNA viral infections by using RNA chain term will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249992